Astellas

Orphan Drug Status for Astellas' Candidate

Orphan Drug Status for Astellas' Candidate

Yahoo/Zacks

Amgen to make move into Japan, takes on Astellas as partner

Amgen to make move into Japan, takes on Astellas as partner

Yahoo/Reuters

This Week in Biotech

This Week in Biotech

Motley Fool

Astellas and Medivation Announce Submission of Application for Marketing Approval of Enzalutamide, an Oral Androgen Receptor Inhibitor, in Japan

Astellas and Medivation Announce Submission of Application for Marketing Approval of Enzalutamide, an Oral Androgen Receptor Inhibitor, in Japan

Yahoo/BusinessWire

A Few Hundred More Pharma Jobs Are Being Cut

A Few Hundred More Pharma Jobs Are Being Cut

Pharmalot

AstraZeneca, Cubist, Astellas Said to Make Bids for Optimer

AstraZeneca, Cubist, Astellas Said to Make Bids for Optimer

Bloomberg

Astellas forecasts big sales growth as prostate drug catches hold

Astellas forecasts big sales growth as prostate drug catches hold

Fierce Pharma

Astellas, GSK vie to make 'high altitude' anemia pill

Astellas, GSK vie to make 'high altitude' anemia pill

Reuters

GSK’s Contract Manufacturing Delays Cause Shortage of Restless Leg Treatment

GSK’s Contract Manufacturing Delays Cause Shortage of Restless Leg Treatment

Outsourcing Pharma